# Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/oncology-therapeutic-radiopharmaceuticals-dosage-optimization-during-clinical-development-draft-guidance-for-industry/401e294a-8da1-4a1d-9457-e02da07a92af

> FDA guidance document: Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development: Draft Guidance for Industry. Issue date: August 19, 2025. Get complete insights and analysis.

---

## Details

- Title: Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2025-08-19
- Comment Close Date: 2025-10-20
- Last Changed: 2025-08-18
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2025-D-1757">FDA-2025-D-1757</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Tissue Agnostic Drug Development in Oncology: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/tissue-agnostic-drug-development-in-oncology-draft-guidance-for-industry/3835823e-c995-46e5-98c7-9422ad94971f)
- [Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/gastroparesis-clinical-evaluation-of-drugs-for-treatment-guidance-for-industry/4b7bc445-8e11-4ce8-a6d6-3439f06daab5)